These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 21070231)

  • 1. Amitriptyline in the prophylactic treatment of migraine and chronic daily headache.
    Couch JR;
    Headache; 2011 Jan; 51(1):33-51. PubMed ID: 21070231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
    Dodick DW; Mauskop A; Elkind AH; DeGryse R; Brin MF; Silberstein SD;
    Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind randomized controlled trial of topiramate and amitriptyline either alone or in combination for the prevention of migraine.
    Keskinbora K; Aydinli I
    Clin Neurol Neurosurg; 2008 Dec; 110(10):979-84. PubMed ID: 18620801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of spinal manipulation, amitriptyline and the combination of both therapies for the prophylaxis of migraine headache.
    Nelson CF; Bronfort G; Evans R; Boline P; Goldsmith C; Anderson AV
    J Manipulative Physiol Ther; 1998 Oct; 21(8):511-9. PubMed ID: 9798179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectiveness and tolerance of amitriptyline oxide in chronic tension headache--a multicenter double-blind study versus amitriptyline versus placebo].
    Pfaffenrath V; Diener HC; Isler H; Meyer C; Scholz E; Taneri Z; Wessely P; Zaiser-Kaschel H; Haase W; Fischer W
    Nervenarzt; 1993 Feb; 64(2):114-20. PubMed ID: 8450893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin type A versus amitriptyline for the treatment of chronic daily migraine.
    Magalhães E; Menezes C; Cardeal M; Melo A
    Clin Neurol Neurosurg; 2010 Jul; 112(6):463-6. PubMed ID: 20399553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID study.
    Lipton RB; Silberstein S; Dodick D; Cady R; Freitag F; Mathew N; Biondi DM; Ascher S; Olson WH; Hulihan J
    Cephalalgia; 2011 Jan; 31(1):18-30. PubMed ID: 20974598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of withdrawal therapy in subjects with chronic daily headache and medication overuse following prophylaxis with topiramate and amitriptyline.
    Valguarnera F; Tanganelli P
    Neurol Sci; 2010 Jun; 31 Suppl 1():S175-7. PubMed ID: 20464616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A double-blind comparative study of the effectiveness and tolerance of paroxetine and amitriptyline in treatment of breast cancer patients with clinically assessed depression].
    Möslinger-Gehmayr R; Zaninelli R; Contu A; Oberhoff C; Gutschow K; Schindler AE; Staab HJ
    Zentralbl Gynakol; 2000; 122(4):195-202. PubMed ID: 10795116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the prophylactic efficacy of amitriptyline and citalopram, alone or in combination, in patients with comorbidity of depression, migraine, and tension-type headache.
    Rampello L; Alvano A; Chiechio S; Malaguarnera M; Raffaele R; Vecchio I; Nicoletti F
    Neuropsychobiology; 2004; 50(4):322-8. PubMed ID: 15539864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
    Fawcett J; Barkin RL
    J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dextroamphetamine pilot crossover trials and n of 1 trials in patients with chronic tension-type and migraine headache.
    Haas DC; Sheehe PR
    Headache; 2004; 44(10):1029-37. PubMed ID: 15546268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized, double-blind, placebo-controlled, proof-of-concept study of the cortical spreading depression inhibiting agent tonabersat in migraine prophylaxis.
    Goadsby PJ; Ferrari MD; Csanyi A; Olesen J; Mills JG;
    Cephalalgia; 2009 Jul; 29(7):742-50. PubMed ID: 19222510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prophylactic treatment of chronic daily headache.
    Mathew NT
    Headache; 2006; 46(10):1552-64. PubMed ID: 17115988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial comparing amitriptyline versus topiramate for the prophylaxis of chronic daily headache in pediatric patients.
    Sezer T; Kandemir H; Alehan F
    Int J Neurosci; 2013 Aug; 123(8):553-6. PubMed ID: 23421731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache.
    Bendtsen L; Jensen R; Olesen J
    J Neurol Neurosurg Psychiatry; 1996 Sep; 61(3):285-90. PubMed ID: 8795600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is anxious-agitated major depression responsive to fluoxetine? A double-blind comparison with amitriptyline.
    Marchesi C; Ceccherininelli A; Rossi A; Maggini C
    Pharmacopsychiatry; 1998 Nov; 31(6):216-21. PubMed ID: 9930635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of migraine attacks. First-choice treatments.
    Prescrire Int; 2015 Feb; 24(157):47-8. PubMed ID: 25802922
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.